Tag: Syros Pharmaceuticals

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Syros Pharmaceuticals

Syros Pharmaceuticals (SYRS) Receives $22.43 Average Price Target from Analysts

Added to Collection on: 2018-07-06 22:59:53

Tags for this article:

Financial analyst
Syros Pharmaceuticals

Click the tags to see associated articles and topics

View Article Details
Syros Pharmaceuticals (SYRS) Holdings Increased by Schwab Charles Investment Management Inc.

Added to Collection on: 2018-07-07 17:33:45

Tags for this article:

Pharmaceuticals policy
Pharmaceutical industry in China
Science and technology in the People's Republic of China
Syros Pharmaceuticals

Click the tags to see associated articles and topics

View Article Details
Syros Pharmaceuticals' (SYRS) “Buy” Rating Reiterated at Cowen

Added to Collection on: 2018-07-17 04:15:23

Tags for this article:

Financial analyst
Subdivisions of Greece
Tourism in Greece
Cyclades
Syros
Aegean islands
Syros Pharmaceuticals
South Aegean

Click the tags to see associated articles and topics

View Article Details
Syros Pharmaceuticals' (SYRS) Buy Rating Reaffirmed at Cowen

Added to Collection on: 2018-07-17 19:15:00

Tags for this article:

Financial analyst
Syros Pharmaceuticals

Click the tags to see associated articles and topics

View Article Details
Cowen Reaffirms “Buy” Rating for Syros Pharmaceuticals (SYRS)

Added to Collection on: 2018-08-09 07:34:42

Tags for this article:

Economy
Stock market
Stock
Corporate finance
Subdivisions of Greece
Syros
Aegean islands
Syros Pharmaceuticals

Click the tags to see associated articles and topics

View Article Details
Syros Pharmaceuticals (NASDAQ:SYRS) Receives Buy Rating from Cann

Added to Collection on: 2018-08-17 00:07:30

Tags for this article:

Stock market
Stock
Corporate finance
Syros Pharmaceuticals

Click the tags to see associated articles and topics

View Article Details
Syros Pharmaceuticals (NASDAQ:SYRS) Price Target Cut to $16.00

Added to Collection on: 2019-10-19 19:26:15

Tags for this article:

Financial markets
Finance
Money
Corporate finance
Stock
Stock market
NASDAQ
Syros
Ermoupoli
Short
Syros Pharmaceuticals

Click the tags to see associated articles and topics

View Article Details
Syros Acquires Clinical-Stage Drug Candidate for Acute Promyelocytic Leukemia, Expanding Its ...

Added to Collection on: 2020-12-05 17:26:15

Tags for this article:

Health sciences
Health
Branches of biology
Equity securities
Options
Corporate finance
Acute promyelocytic leukemia
Warrant
Acute myeloid leukemia
Security
Retinoic acid receptor alpha
Clinical trial
Orsenix LLC
Syros Pharmaceuticals

Click the tags to see associated articles and topics

View Article Details
Roche to Study Syros' CDK7 Inhibitor With Tecentriq in BRAF-Mutated Colorectal Cancer Patients

Added to Collection on: 2021-08-05 14:45:09

Tags for this article:

Clinical medicine
Cancer immunotherapy
Medicine
Health sciences
Breakthrough therapy
Orphan drugs
Atezolizumab
Checkpoint inhibitor
Roche
Cyclin-dependent kinase 7
Immunotherapy
Syros Pharmaceuticals

Click the tags to see associated articles and topics

View Article Details
NERV Stock Forecast, Price & News (Minerva Neurosciences) - MarketBeat

Added to Collection on: 2022-07-16 01:34:39

Tags for this article:

Aphrodisiacs
Peptides
PLX
Bremelanotide
Syros Pharmaceuticals
BioLineRx
BeyondSpring
Palatin Technologies
9 Meters Biopharma
Bioxytran
Terns Pharmaceuticals
PLx Pharma
vTv Therapeutics
sensei biotherapeutics
InflaRx
Infinity Pharmaceuticals

Click the tags to see associated articles and topics

View Article Details